|
|
|
Volumn 2 Suppl 1, Issue , 2001, Pages
|
|
Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONTRAST MEDIUM;
CREATININE;
DOPAMINE RECEPTOR STIMULATING AGENT;
FENOLDOPAM;
RADIOPHARMACEUTICAL AGENT;
ACUTE KIDNEY FAILURE;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CHI SQUARE DISTRIBUTION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
FOLLOW UP;
HUMAN;
KIDNEY FUNCTION TEST;
MALE;
METHODOLOGY;
MIDDLE AGED;
PROBABILITY;
PROSPECTIVE STUDY;
RADIOGRAPHY;
RISK ASSESSMENT;
RISK FACTOR;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
URINE;
AGED;
AGED, 80 AND OVER;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CHI-SQUARE DISTRIBUTION;
CONTRAST MEDIA;
CORONARY ANGIOGRAPHY;
CORONARY DISEASE;
CREATININE;
DOPAMINE AGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FENOLDOPAM;
FOLLOW-UP STUDIES;
HUMANS;
KIDNEY FAILURE, ACUTE;
KIDNEY FUNCTION TESTS;
MALE;
MIDDLE AGED;
PROBABILITY;
PROSPECTIVE STUDIES;
RADIOPHARMACEUTICALS;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0035751401
PISSN: 15306550
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (32)
|
|
References (0)
|
